Extra corporeal membrane oxygenation in the therapy of cardiogenic shock (ECMO ‐CS): rationale and design of the multicenter randomized trial

ConclusionThe results of the ECMO‐CS trial may significantly influence current practice in the management of patients with severe and rapidly deteriorating cardiogenic shock. ECMO‐CS trial registration number is NCT02301819.

http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fejhf.857

Source: European Journal of Heart Failure - May 4, 2017 Category: Cardiology Authors: Petr Ostadal, Richard Rokyta, Andreas Kruger, Dagmar Vondrakova, Marek Janotka, Ondrej Sm íd, Jana Smalcova, Milan Hromadka, Ales Linhart, Jan Bělohlávek Tags: Supplement Article Source Type: research